Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Edmond N. Kelly to Angiogenesis Inhibitors

This is a "connection" page, showing publications Edmond N. Kelly has written about Angiogenesis Inhibitors.

 
Connection Strength
 
 
 
0.393
 
  1. Raghuram K, Isaac M, Yang J, AlAli A, Mireskandari K, Ly LG, Kelly E, Banihani R, Shah PS, Tehrani N. Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser. J Perinatol. 2019 09; 39(9):1300-1308.
    View in: PubMed
    Score: 0.219
  2. Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN, Shah V, Shah PS, Kelly EN. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity. Pediatrics. 2016 Apr; 137(4).
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.